These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3548954)

  • 41. An automatic encoding deficit in the amnesia of Korsakoff's syndrome.
    Kohl D; Brandt J
    Ann N Y Acad Sci; 1985; 444():460-2. PubMed ID: 3860098
    [No Abstract]   [Full Text] [Related]  

  • 42. Characteristics of the memory loss of a patient with Wernicke-Korsakoff's syndrome without alcoholism.
    Becker JT; Furman JM; Panisset M; Smith C
    Neuropsychologia; 1990; 28(2):171-9. PubMed ID: 2314572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamics of the cognitive procedural learning in alcoholics with Korsakoff's syndrome.
    Beaunieux H; Pitel AL; Witkowski T; Vabret F; Viader F; Eustache F
    Alcohol Clin Exp Res; 2013 Jun; 37(6):1025-32. PubMed ID: 23278323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of reboxetine on salivary MHPG concentration and cognitive symptoms among patients with alcohol-related Korsakoff's syndrome.
    Reuster T; Buechler J; Winiecki P; Oehler J
    Neuropsychopharmacology; 2003 May; 28(5):974-8. PubMed ID: 12644844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Wernicke-Korsakoff syndrome: a review of psychological, neuropathological and etiological factors.
    Butters N
    Curr Alcohol; 1981; 8():205-32. PubMed ID: 6806017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Memory of alcoholic patients, including Korsakoff's, tested with a Brown-Peterson paradigm.
    Kessler J; Markowitsch HJ; Bast-Kessler C
    Arch Psychol (Frankf); 1987; 139(2):115-32. PubMed ID: 3442472
    [No Abstract]   [Full Text] [Related]  

  • 47. Cortical and diencephalic lesions in Korsakoff's syndrome: a clinical and CT scan study.
    Jacobson RR; Lishman WA
    Psychol Med; 1990 Feb; 20(1):63-75. PubMed ID: 2320699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoamine activity correlates with psychometric deficits in Korsakoff's disease.
    Mair RG; McEntee WJ; Zatorre RJ
    Behav Brain Res; 1985 May; 15(3):247-54. PubMed ID: 2408635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The etiology and neuropathology of alcoholic Korsakoff's syndrome. Some evidence for the role of the basal forebrain.
    Salmon DP; Butters N
    Recent Dev Alcohol; 1987; 5():27-58. PubMed ID: 2951772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal gradients in the retrograde amnesia of patients with alcoholic Korsakoff's disease.
    Albert MS; Butters N; Levin J
    Arch Neurol; 1979 Apr; 36(4):211-6. PubMed ID: 426664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Memory disorder in Korsakoff's psychosis: a neuropathological and neuropsychological investigation of two cases.
    Mair WG; Warrington EK; Weiskrantz L
    Brain; 1979 Dec; 102(4):749-83. PubMed ID: 116710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.
    Mohs RC; Davis BM; Greenwald BS; Mathé AA; Johns CA; Horvath TB; Davis KL
    J Am Geriatr Soc; 1985 Nov; 33(11):749-57. PubMed ID: 2865282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Choline chloride effects on memory in the elderly.
    Mohs RC; Davis KL; Tinklenberg JR; Hollister LE
    Neurobiol Aging; 1980; 1(1):21-5. PubMed ID: 7266731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Post-traumatic Korsakoff's syndrome: clinical and anatomical report].
    Brion S; Plas J; Mikol J; Jeanneau A; Brion F
    Encephale; 2001; 27(6):513-25. PubMed ID: 11865559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential patterns of memory loss in patients with Alzheimer's disease and Korsakoff's disease.
    Irle E; Kaiser P; Naumann-Stoll G
    Int J Neurosci; 1990 May; 52(1-2):67-77. PubMed ID: 2265925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease.
    Harrell LE; Jope RS; Falgout J; Callaway R; Avery C; Spiers M; Leli D; Morere D; Halsey JH
    J Am Geriatr Soc; 1990 Feb; 38(2):113-22. PubMed ID: 2405043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response shifting and inhibition, but not working memory, are impaired after long-term heavy alcohol consumption.
    Hildebrandt H; Brokate B; Eling P; Lanz M
    Neuropsychology; 2004 Apr; 18(2):203-11. PubMed ID: 15099142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outpatient treatment of senile dementia with oral physostigmine.
    Beller SA; Overall JE; Rhoades HM; Swann AC
    J Clin Psychiatry; 1988 Oct; 49(10):400-4. PubMed ID: 3049561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Korsakoff's psychosis in the presence of multiple sclerosis: an unusual cognitive state.
    Ron MA; Feinstein A
    J Neurol Neurosurg Psychiatry; 1990 Jul; 53(7):625. PubMed ID: 2391534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.